Category of the product: Product from cannabis for medical use
Type of ATC Product:§KANOBIL® CANC+ is dispensed on prescription in duplicate upon recommendation of medical doctor, specialist in oncology or haematology.
triangle, absolute prohibition on driving a motor vehicle or handling machines.
§ – narcotic drug
Product Name: KANOBIL® CANC+
cannabis oil extract for medical use
Generics: tetrahydrocannabinol (THC), cannabidiol (CBD)
Oil solution for oral administration
(10 mg tetrahydrocannabinol (THC) and
10 mg cannabidiol (CBD))/ 1 ml
(1200 mg tetrahydrocannabinol (THC) and
1200 mg cannabidiol (CBD))120 ml

The text is not intended for self-medication!
Text is intended for informative purposes of healthcare workers.

tetrahydrocannabinol (THC), cannabidiol (CBD)


Stick strictly to the recommendations from your doctor. The therapy has to be recommended and monitored by a doctor, specialist in oncology or haematology.
Your doctor will tell you how many doses per day you should take and when. You must not change the doses or discontinue the treatment without consulting your doctor.
KANOBIL® CANC+ is for oral use.

Treatment with KANOBIL® CANC+ is not introducing treatment, but treatment for continuing with already started treatment in patients at whom, according to assessment of recommending physician, higher dosages are needed.

Shake the bottle before use. Use the plastic graduated syringe for pulling out a dose of the oil solution which is equal to the dose in accordance to the scheme given by your doctor.
Carefully press to release the content of the dosing syringe in the mouth and slowly swallow.

You can take KANOBIL® CANC+ with or without food. However, taking KANOBIL® CANC+ with food can affect the amount your body takes in.
You should try, as far as possible, to take KANOBIL® CANC+ the same way in relation to food each time, so you get the same effect each time.

Daily dose of KANOBIL® CANC+ as continuing treatment to already started treatment is defined by physician who has recommended the treatment. Recommendation is made according to the assessment of patient condition; taking into consideration that one millilitre (1mL) of KANOBIL® CANC+ contains 10 mg tetrahydrocannabinol (THC) and 10 mg cannabidiol (CBD).
During the therapy course, at every 4, 8 and 12 weeks, a laboratory control has to be performed for haematological, hepatic and renal analyses in order to monitor the occurrence of side effects and tolerance to them. In case of variations that surpass the benefit/risk ratio and when there is no improvement of the clinical status, discontinuation of therapy should be considered.


KANOBIL® CANC+ should not be recommended for use in children and adolescents aged below 18, due to lack of safety and efficacy information.



(10 mg tetrahydrocannabinol (THC) and 10 mg cannabidiol (CBD))/ 1 ml
(1200 mg tetrahydrocannabinol (THC) and 1200 mg cannabidiol (CBD))120 ml


KANOBIL® CANC+ can be administered in adult patients as symptomatic adjuvant therapy to the regular therapy in cases of:
Malignant diseases - for improvement of the symptoms of:
-Chemotherapy-induced nausea and vomiting in patients in whom the standard therapy with other anti-nausea medicinal products (such as 5-HT3 agonists) does not produce the expected results.


Do not take KANOBIL® CANC+ if:
-if you are hypersensitive to cannabinoids or to any of the excipients;
-if you or anyone from your family has any issues related to the mental health, like schizophrenia, psychoses or other sever psychiatric conditions; this does not include the depression which results from your primary condition;
-if you are pregnant or breastfeeding.
Do not take KANOBIL® CANC+ if any of the above applies to you. If you are not sure, talk to your doctor or pharmacist before taking KANOBIL® CANC+.


A box with a glass bottle containing 120 ml of the oil solution (equal to 120 doses) and a plastic graduated dosing syringe.

Prescription in two copies with the mark “copy” on the second copy and with the ordinal number from the evidence book of prescribed medicines containing narcotics and psychotropic substances.